The race to develop the next generation of weight loss drugs has taken an interesting new turn. In recent research, Eli Lilly ...

This week, the White House announced a deal with Eli Lilly and Novo Nordisk to lower the cost of their GLP-1 weight loss drugs, Wegovy and Zepbound. The move could significantly expand access to these ...

As weight-loss drugs grow more popular, experts warn of the risks of using them without supervision for quick, cosmetic ...

The drugs have become popular for their significant weight-loss effects, but their high cost has made them inaccessible for ...

The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all these options stack up. Are there benefits to one over the other? How do side ...

Forbes Health has ranked the best providers for pricing, patient care, effectiveness and ease of use. This way you can cut through the scams and noise to make an informed decision when choosing an ...

Because these drugs have become particularly popular among women 50 to 64 years old, Mom and Nonna are helming the Great ...

As the use of GLP-1 agonists such as semaglutide and tirzepatide for weight loss becomes increasingly common in adults, and obesity continues to increase in children and adolescents, should these ...

Trial participants who used eloralintide, a new weight loss medication that, instead of focusing on the hormone GLP-1, ...

Pregnancy and semaglutide — the active ingredient in GLP-1 drugs such as Ozempic for Type 2 diabetes and Wegovy for weight loss — don’t mix. But what about breastfeeding? Women should stop taking ...

The maker of the weight loss and diabetes drugs Wegovy and Ozempic has cut the prices for most versions of the blockbuster medications.